9 Feb 2010 09:28
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS
WITH RECOGNISED INTERMEDIARY STATUS
DEALING IN A CLIENT-SERVING CAPACITY
(Rule 38.5(a) of the Takeover Code)
1. KEY INFORMATION
| Name of exempt principal trader | Seymour Pierce Limited |
| Company dealt in | Fulcrum Pharma plc |
| Class of relevant security to which the dealings being disclosed relate (Note 1) | Ordinary 1p Shares |
| Date of dealing | 08.02.10 |
2. DEALINGS (Note 2)
(a) Purchases and sales
| Total number of securities purchased
| Highest price paid (Note 3) | Lowest price paid (Note 3) |
|
|
|
|
| Total number of securities sold
| Highest price received (Note 3) | Lowest price received (Note 3) |
| 100,000 | 0.03675 GBP | 0.03675 GBP |
(b) Derivatives transactions (other than options)
| Product name, e.g. CFD | Long/short (Note 4) | Number of securities (Note 5) | Price per unit (Note 3) |
|
|
|
|
|
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
| Product name, e.g. call option
| Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
|
(ii) Exercising
| Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3)
|
|
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. |
|
|
| Date of disclosure | 09.02.10 |
| Contact name | Lynette Patterson |
| Telephone number | 020 7107 8022 |
| Name of offeree/offeror with which connected | Fulcrum Pharma plc |
| Nature of connection (Note 6) | Nomad and Broker |
Notes
The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk